Changes in Radiotherapeutic Management of Head and Neck Cancer: A 30-Year Perspective

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2 SUPPL., 2007, Pages

  Peters, Lester J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CETUXIMAB; CYTOTOXIN; NIMORAZOLE; RADIOSENSITIZING AGENT; TIRAPAZAMINE; VIRUS DNA;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTED TOMOGRAPHY SCANNER; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EPSTEIN BARR VIRUS; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MORBIDITY; MOUTH CANCER; MOUTH CAVITY; NASOPHARYNX CARCINOMA; PHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION ONCOLOGY; RADIOBIOLOGY; TECHNOLOGY, RADIOLOGIC;

EID: 34548458985     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.078     Document Type: Article

References (15)

1. MacComb W.S., and Fletcher G.H. Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. AJR Am J Roentgenol Radium Ther Nucl Med 77 (1957) 397-414
2. Lee A.W.M., Sze W.M., Au J.S.K., et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys 61 (2005) 107-116
3. Poceddu S.V., Jamolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
4. Mendenhall W.M., Amdur R.J., and Palta J.R. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 24 (2006) 2618-2623
5. Amdur R.J., Li J.G., Liu C., et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26 (2004) 257-263
6. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 368 (2006) 843-854
7. Peters L.J., and Withers H.R. Applying radiobiological principles to combined modality treatment of head and neck cancer-The time factor. Int J Radiat Oncol Biol Phys 39 (1997) 831-836
8. Pignon J.P., Bourhis J., Domenge C., et al., for the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
9. Adelstein D.J., and LeBlanc M. Does induction chemotherapy have a role in the management of locally advanced head and neck cancer?. J Clin Oncol 24 (2006) 2624-2628
10. Overgaard J., Hansen H.S., Overgaard M., et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma: Results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother Oncol 46 (1998) 135-146
11. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
12. Ma B.B., King A., Lo Y.M., et al. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 714-720
13. Rischin D., Hicks R.J., Fisher R., et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group study 98.02. J Clin Oncol 24 (2006) 2098-2104
14. Steiner W., and Ambrosch P. Endoscopic laser surgery of the upper aerodigestive tract with special emphasis on cancer surgery (2000), Thieme, Stuttgart
15. Peters L.J. Through a glass darkly: Predicting the future of radiation oncology. Int J Radiat Oncol Biol Phys 31 (1995) 219-225